Next Article in Journal
Nanocarriers for the Delivery of Neuroprotective Agents in the Treatment of Ocular Neurodegenerative Diseases
Next Article in Special Issue
Safety Evaluation and Population Pharmacokinetics of Camostat Mesylate and Its Major Metabolites Using a Phase I Study
Previous Article in Journal
Virtual Screening, Structural Analysis, and Formation Thermodynamics of Carbamazepine Cocrystals
Previous Article in Special Issue
Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(3), 838; https://doi.org/10.3390/pharmaceutics15030838
Action Date Notes Link
article pdf uploaded. 3 March 2023 16:48 CET Version of Record https://www.mdpi.com/1999-4923/15/3/838/pdf-vor
article xml uploaded. 7 March 2023 03:34 CET Original file https://www.mdpi.com/1999-4923/15/3/838/xml
article pdf uploaded. 7 March 2023 03:34 CET Updated version of record https://www.mdpi.com/1999-4923/15/3/838/pdf
article html file updated 7 March 2023 03:36 CET Original file -
article html file updated 20 March 2023 20:42 CET Update https://www.mdpi.com/1999-4923/15/3/838/html
Back to TopTop